Action by the lungs on circulating xenobiotic agents, with a case study of physiologically based pharmacokinetic modeling of benzo(a)pyrene disposition
- PMID: 2293237
- DOI: 10.1016/0163-7258(90)90078-g
Action by the lungs on circulating xenobiotic agents, with a case study of physiologically based pharmacokinetic modeling of benzo(a)pyrene disposition
Abstract
The lungs contain enzyme systems that metabolize xenobiotic agents, and the structure and position in the circulation render this organ potentially important in the metabolic removal of substances from the blood. Pulmonary enzyme systems that oxidize xenobiotic agents include cytochrome P450- or flavin-containing monooxygenases. In addition, the lungs accumulate certain agents, notably basic amines, without substantially metabolizing them. Benzo(a)pyrene (B(a)P) is one example of a xenobiotic agents that is eliminated from the circulation largely by oxidative metabolism. We have described the metabolic elimination of B(a)P using a physiologically based pharmacokinetic model applied retrospectively to existing data sets of B(a)P metabolism and disposition in rats. The result suggests that the lungs may, under certain conditions, contribute significantly to xenobiotic disposition and that this contribution is greater than that predicted by the activity of dispositional enzyme in this organ. Thus, the lungs may play a significant role in the metabolic elimination of some xenobiotic agents under certain circumstances.
Similar articles
-
Mitigating role of baicalein on lysosomal enzymes and xenobiotic metabolizing enzyme status during lung carcinogenesis of Swiss albino mice induced by benzo(a)pyrene.Fundam Clin Pharmacol. 2014 Jun;28(3):310-22. doi: 10.1111/fcp.12036. Epub 2013 Jul 8. Fundam Clin Pharmacol. 2014. PMID: 23834621
-
Biochemistry, physiology and drug metabolism--implications regarding the role of the lungs in drug disposition.Clin Physiol Biochem. 1985;3(2-3):66-79. Clin Physiol Biochem. 1985. PMID: 3891197 Review.
-
The prediction of benzo[a]pyrene clearance by rat liver and lung from enzyme kinetic data.Mol Pharmacol. 1983 Sep;24(2):300-8. Mol Pharmacol. 1983. PMID: 6310365
-
Effect of intratracheally administered lindane on aldrin and benzo(a)pyrene contents in lungs of rats.Toxicol Lett. 1993 Jul;69(1):63-7. doi: 10.1016/0378-4274(93)90146-o. Toxicol Lett. 1993. PMID: 7689255
-
Sites for xenobiotic activation and detoxication within the respiratory tract: implications for chemically induced toxicity.Toxicol Appl Pharmacol. 1988 May;93(3):493-505. doi: 10.1016/0041-008x(88)90053-1. Toxicol Appl Pharmacol. 1988. PMID: 3285523 Review.
Cited by
-
Translating dosimetry of Dibenzo[def,p]chrysene (DBC) and metabolites across dose and species using physiologically based pharmacokinetic (PBPK) modeling.Toxicol Appl Pharmacol. 2022 Mar 1;438:115830. doi: 10.1016/j.taap.2021.115830. Epub 2021 Dec 18. Toxicol Appl Pharmacol. 2022. PMID: 34933053 Free PMC article.
-
Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents.Toxicol Appl Pharmacol. 2011 Dec 15;257(3):365-76. doi: 10.1016/j.taap.2011.09.020. Epub 2011 Sep 29. Toxicol Appl Pharmacol. 2011. PMID: 22001385 Free PMC article.
-
Predicting lung dosimetry of inhaled particleborne benzo[a]pyrene using physiologically based pharmacokinetic modeling.Inhal Toxicol. 2016 Sep;28(11):520-35. doi: 10.1080/08958378.2016.1214768. Inhal Toxicol. 2016. PMID: 27569524 Free PMC article.
-
Lung injury: cell-specific bioactivation/deactivation of circulating pneumotoxins.Int J Exp Pathol. 1995 Dec;76(6):393-401. Int J Exp Pathol. 1995. PMID: 8652359 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources